{"id":"d766448c-b8b9-5be6-89b8-40c448dd2fa9","stable_key":"09b23d0d-35e2-51ff-b1aa-b4f9227e4fa2:isoleucine-iars-clinical-supplement","predicate":"associated_with_improvement_in","statement":"The IARS patients within a small personalized ARS-treatment series received cognate amino-acid supplementation and showed reported clinical benefit during follow-up.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"bab14e58-f267-56c9-94f0-78eab8e45bf6","mechanism_event_label":"Some residual-function disorders may respond to carefully selected substrate support.","subject":{"id":"c85b327e-f132-5d9a-8e4b-c2976fcc0373","slug":"isoleucine","display_name":"L-Isoleucine","entity_type_key":"small_molecule"},"object":{"id":"fde83612-cb62-5c03-b38a-4e0bfac2de15","slug":"human-iars1-personalized-treatment","display_name":"Personalized isoleucine treatment in IARS deficiency","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"bab14e58-f267-56c9-94f0-78eab8e45bf6","stable_key":"09b23d0d-35e2-51ff-b1aa-b4f9227e4fa2:isoleucine-iars-clinical-supplement-event","event_type":"observed_relationship","label":"Some residual-function disorders may respond to carefully selected substrate support.","description":"The IARS patients within a small personalized ARS-treatment series received cognate amino-acid supplementation and showed reported clinical benefit during follow-up.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"c85b327e-f132-5d9a-8e4b-c2976fcc0373","slug":"isoleucine","display_name":"L-Isoleucine","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"fde83612-cb62-5c03-b38a-4e0bfac2de15","slug":"human-iars1-personalized-treatment","display_name":"Personalized isoleucine treatment in IARS deficiency","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"fe83b156-e71e-5193-a958-0665af0e55ae","slug":"iars1","display_name":"Human cytosolic isoleucyl-tRNA synthetase / IARS1","entity_type_key":"protein"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_access","value_text":"Primary abstract","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Uncontrolled human case series with preclinical patient-cell testing; multiple different ARS disorders.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Do not attribute every pooled outcome to IARS or generalize to all IARS variants; not a randomized trial.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"L-Isoleucine collection; species, compartment, exposure, co-substrates and manipulation remain explicit.","comparator":null,"unit":null,"notes":"","entity":{"slug":"isoleucine","display_name":"L-Isoleucine","entity_type_key":"small_molecule"}},{"dimension":"plain_language","value_text":"Some residual-function disorders may respond to carefully selected substrate support.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Treatment of ARS deficiencies with specific amino acids. · 2021 · https://pubmed.ncbi.nlm.nih.gov/34194004/ · DOI 10.1038/s41436-021-01249-z","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"72b44632-9c33-5974-a6a2-04039c8043d6","evidence_kind":"source_excerpt","locator":"Lines 138-144","start_line":138,"end_line":144,"excerpt":"## isoleucine-iars-clinical-supplement\nSome residual-function disorders may respond to carefully selected substrate support.\nThe IARS patients within a small personalized ARS-treatment series received cognate amino-acid supplementation and showed reported clinical benefit during follow-up.\nModel: Uncontrolled human case series with preclinical patient-cell testing; multiple different ARS disorders.\nLimitations: Do not attribute every pooled outcome to IARS or generalize to all IARS variants; not a randomized trial.\nEvidence access: Primary abstract\nTreatment of ARS deficiencies with specific amino acids. · 2021 · https://pubmed.ncbi.nlm.nih.gov/34194004/ · DOI 10.1038/s41436-021-01249-z","model_system":"Uncontrolled human case series with preclinical patient-cell testing; multiple different ARS disorders.","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Original curation paraphrase; evidence access and experimental limitations specified.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"4b00f118-00fd-5cef-be97-13125eb958e9","stable_key":"import-09b23d0d-35e2-51ff-b1aa-b4f9227e4fa2","title":"L-Isoleucine: transport, translation, catabolism and cross-nutrient mechanisms (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text.","file_path":"","sha256":"2058ff0da379586994e7fda6ae0086c60fa3173542bfaf1fb3871ad3e09f9c6c","revision_id":"f32192d4-9913-5d35-acbc-cf90ff17995e","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}